Colossal Biosciences ne apna naya AI platform 'GenoMorph' launch kiya hai. Ye tool Dodo jaise extinct species ke genetic data gaps ko bharega aur gene-editing research ko fast track karega. Saath hi, NeoGenesis Capital fund ke through ye technology ab health aur agriculture sector mein bhi expand hogi.
AI ka kamaal, ab biology hogi fast!
Colossal Biosciences ne finally apna naya AI tool GenoMorph market mein utaar diya hai. Asal mein, Dodo jaise extinct birds par kaam karte waqt genetic material ki kami ek bada hurdle thi. Ab GenoMorph comparative biology aur 3D morphology ka use karke genetic markers map kar raha hai.
Kaise kaam karta hai ye tool?
Ye AI 70 se zyada bird species ke 3D skull measurements aur chickens/quail ke developmental data par trained hai. Iska result ye hai ki company ne Dodo project ke liye already 2,300 genetic targets identify kar liye hain. Pehle jahan trial-and-error mein saalon lag jaate the, ab researchers seedha promising genetic regions par focus kar sakte hain.
Lab process mein bhi tezi
Sirf AI nahi, company ne process speed-up karne ke liye lipid nanoparticles ka use shuru kiya hai. Isse gene-editing tools seedha avian embryos mein deliver ho rahe hain, jisse results dekhne ka wait time drastic reduce ho gaya hai.
Investors aur Business potential
Ab focus sirf science nahi, balki commercial scalability par hai. Peter Diamandis (XPRIZE founder) ne NeoGenesis Capital naam ka naya venture capital fund launch kiya hai, jo specifically Colossal ke platform use karne wali companies ko back karega. Iska matlab saaf hai—synthetic biology ki ye tech sirf de-extinction tak limit nahi rahegi, balki health aur agriculture jaise bade sectors mein bhi disrupt karegi.